Multi-Regional Clinical Trials Including China: Best Practices
Multi-Regional Clinical Trials Including China: Best Practices Best Practices for Conducting Multi-Regional Clinical Trials in China Introduction China’s inclusion in multi-regional clinical trials (MRCTs) has become a strategic priority for global sponsors. With a vast patient population, expanding trial infrastructure, and regulatory reforms under the National Medical Products Administration (NMPA), China now plays a central…
Read More “Multi-Regional Clinical Trials Including China: Best Practices” »